A randomized phase II study comparing atezolizumab after concurrent chemoradiotherapy with chemoradiotherapy alone in limited disease small-cell lung cancer

Clinical Studies - Jan 29, 2020 - Dec 31, 2030

Ongoing

Project leader: Appenzeller-Herzog Christian
Members: Demmer-Steingruber Ruth, Müller Fiona